U.S. stocks have been roaring higher for two straight years, giving the S&P 500 an eye-popping 58% gain over that stretch, according to Dow Jones Market Data. If the advance holds, it would mark the ...
Investors considering Monopar should keep a close eye out for announcements about further development of ALXN-1840. Any updates on its MNPR-101 line of oncology products, all of which are either in ...